发明名称 Method For Assessing the Predisposition and/or Susceptibility to Copd by Analysing Fgf-Bp1
摘要 The present invention relates to the discovery of an association between the gene encoding FGF-BP1 (fibroblast growth factor-binding protein) and chronic obstructive pulmonary disease (COPD). The invention identifies a role for FGF-BP1 in COPD. The present invention therefore relates to diagnostic techniques for the detection of COPD by detecting all or part of this gene, its precursors or products (mRNA, cDNA, genomic DNA, or protein). The present invention also provides methods and as-says for identifying compounds which modulate FGF-BP1 and which may be used for treating respiratory diseases such as COPD. Furthermore, the invention relates to polymorphisms in the genes encoding FGF-BP1. The invention also relates to the use of polymorphisms in the FGF-BP1-encoding genes in assessing predisposition and/or susceptibility of an individual to chronic obstructive pulmonary disease (COPD).
申请公布号 US2008167326(A1) 申请公布日期 2008.07.10
申请号 US20060910092 申请日期 2006.04.03
申请人 ASTRAZENECA AB 发明人 KOOPMANN WITTE;SMITH SIMON
分类号 A61K31/522;C12Q1/68;G01N33/53 主分类号 A61K31/522
代理机构 代理人
主权项
地址